Beranda › Penyakit Sel Sabit › Distrik Columbia
Uji klinis Penyakit Sel Sabit di Distrik Columbia
10 studi untuk Penyakit Sel Sabit mencari peserta di lokasi di Distrik Columbia.
Kota di Distrik Columbia
Teks studi resmi (Bahasa Inggris)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- Childrens National Hospital, Washington D.C.
Menerima pesertaFase 3
Usia 12 hingga 100 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06439082A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Childrens National Medical Ctr, Washington D.C.
- MedStar Hlth Res Institute, Washington D.C.
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06612268ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Georgetown University, Washington D.C.
- Children's National Hemophilia Center, Washington D.C.
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04398628Cooperative Assessment of Late Effects for SCD Curative Therapies
- Children's National Medical Center, Washington D.C.
Menerima pesertaStudi observasional
Usia 4 hingga 65 · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05153967Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
- Children's National Hospital (MRD-HCT), Washington D.C.
Menerima pesertaStudi observasional
Usia 3 hingga 20 · Semua jenis kelamin · Diperbarui 4 Jun 2026 · NCT06941389Intravenous L-Citrulline for Vaso-occlusive Pain Episode in Sickle Cell Disease
- Children's National Hospital, Washington D.C.
Menerima pesertaFase 2
Usia 4 hingga 21 · Semua jenis kelamin · Diperbarui 13 Apr 2026 · NCT06635902Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
- Children's National Health System, Washington D.C.
Menerima pesertaFase 2
Usia 2 hingga 25 · Semua jenis kelamin · Diperbarui 10 Mar 2026 · NCT03587272Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
- Children's National Hospital, Washington D.C.
Menerima pesertaFase 2
Usia 2 hingga 25 · Semua jenis kelamin · Diperbarui 26 Sep 2025 · NCT06358638Advancing Feasibility and Acceptability of Digital Cognitive Rehabilitation in Sickle Cell Disease
- Children's National Hospital, Washington D.C.
Menerima peserta
Usia 7 hingga 16 · Semua jenis kelamin · Diperbarui 13 Feb 2025 · NCT06770010Feasibility and Efficacy of Attentional-Control Training in Sickle Cell Disease
- Children's National Hospital, Washington D.C.
Menerima peserta
Usia 8 hingga 16 · Semua jenis kelamin · Diperbarui 10 Jan 2025 · NCT05099874Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.